Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Substituted o6-benzylguanines and 6(4)-benzyloxypyrimidines

  • Read more about Substituted o6-benzylguanines and 6(4)-benzyloxypyrimidines
Patent Cooperation Treaty
PCT/US1995/009702
Filed on 1995-07-31

METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS

  • Read more about METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS
Patent Cooperation Treaty
PCT/US1995/008224
Filed on 1995-07-07

NEW BREFELDIN A DERIVATIVES AND THEIR UTILITY IN THE TREATMENT OF CANCER

  • Read more about NEW BREFELDIN A DERIVATIVES AND THEIR UTILITY IN THE TREATMENT OF CANCER
Patent Cooperation Treaty
PCT/US1995/007854
Filed on 1995-06-29

AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY

  • Read more about AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY
Patent Cooperation Treaty
PCT/US1995/006613
Filed on 1995-05-24

cDNA Cloning of Potentially Transforming Human Ras-related Oncogenes

  • Read more about cDNA Cloning of Potentially Transforming Human Ras-related Oncogenes
Patent Cooperation Treaty
PCT/US1995/006420
Filed on 1995-05-24

PTERIDINE NUCLEOTIDE ANALOGS AS FLUORESCENT DNA PROBES

  • Read more about PTERIDINE NUCLEOTIDE ANALOGS AS FLUORESCENT DNA PROBES
Patent Cooperation Treaty
PCT/US1995/005264
Filed on 1995-04-25

VECTORS WITH MULTIPLE HIV-1 TAR SEQUENCES INHIBITING HIV-1 GENE EXPRESSION

  • Read more about VECTORS WITH MULTIPLE HIV-1 TAR SEQUENCES INHIBITING HIV-1 GENE EXPRESSION
Patent Cooperation Treaty
PCT/US1995/005955
Filed on 1995-05-18

HUMAN PAPILLOMA VIRUS INHIBITION BY A HAIRPIN RIBOZYME

  • Read more about HUMAN PAPILLOMA VIRUS INHIBITION BY A HAIRPIN RIBOZYME
Patent Cooperation Treaty
PCT/US1995/006016
Filed on 1995-05-15

METHODS OF IN VIVO GENE DELIVERY

  • Read more about METHODS OF IN VIVO GENE DELIVERY
Patent Cooperation Treaty
PCT/US1995/005487
Filed on 1995-05-03

COMPOSITION AND METHOD OF STIMULATING PROLIFERATION AND DIFFERENTIATION OF HUMAN FETAL AND ADULT PANCREATIC CELLS EX VIVO

  • Read more about COMPOSITION AND METHOD OF STIMULATING PROLIFERATION AND DIFFERENTIATION OF HUMAN FETAL AND ADULT PANCREATIC CELLS EX VIVO
Patent Cooperation Treaty
PCT/US1995/005521
Filed on 1995-04-28

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1489
  • Page 1490
  • Page 1491
  • Page 1492
  • Page 1493
  • Page 1494
  • Page 1495
  • Page 1496
  • Page 1497
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health